By Associate Professor Jacob Sevastos

Journal articles

Stefani M; Musgrave K; Sevastos J; Penny M; Day RO; Roberts DM, 2023, 'Optimizing the dosing of vancomycin in patients receiving intermittent haemodialysis with low-flux filters, and the potential impact of dosing software', Nephrology, 28, pp. 534 - 539, http://dx.doi.org/10.1111/nep.14198

Barua S; Yang T; Conte S; Bragg C; Sevastos J; Macdonald PS; Muthiah K; Hayward CS, 2022, 'Value of Renal Histology in Predicting Cardiorenal Outcomes in Heart Transplant-listed Patients', Transplantation Direct, 9, pp. E1424, http://dx.doi.org/10.1097/TXD.0000000000001424

Barua S; Muthiah K; Sevastos J; Macdonald P; Hayward C, 2020, '161 Renal Histology associated With Cardiorenal Syndrome in Patients With Advanced Heart Failure', Heart, Lung and Circulation, 29, pp. S107 - S108, http://dx.doi.org/10.1016/j.hlc.2020.09.168

Roberts DM; Sevastos J; Carland JE; Stocker SL; Lea-Henry TN, 2018, 'Clinical pharmacokinetics in kidney disease application to rational design of dosing regimens', Clinical Journal of the American Society of Nephrology, 13, pp. 1254 - 1263, http://dx.doi.org/10.2215/CJN.05150418

Lea-Henry TN; Carland JE; Stocker SL; Sevastos J; Roberts DM, 2018, 'Clinical pharmacokinetics in kidney disease: Fundamental principles', Clinical Journal of the American Society of Nephrology, 13, pp. 1085 - 1095, http://dx.doi.org/10.2215/CJN.00340118

Sharma M; Anthony C; Hayward C; Jabbour A; Keogh AM; Macdonald P; Sevastos J, 2018, 'Life-saving combined heart–kidney transplantation in a previous sequential heart and kidney transplant recipient', European Journal of Case Reports in Internal Medicine, 5, http://dx.doi.org/10.12890/2018_000924

Ruderman I; Sevastos J; Anthony C; Ruygrok P; Chan W; Javorsky G; Bergin P; Snell G; Menahem S, 2015, 'Outcomes of simultaneous heart-kidney and lung-kidney transplantations: The Australian and New Zealand experience', Internal Medicine Journal, 45, pp. 1236 - 1241, http://dx.doi.org/10.1111/imj.12865

Anthony C; Sharma M; Spina R; Macdonald P; Sevastos J, 2015, 'Dose-Adjusted Beta-Lactam Antibiotic-Induced Encephalopathy in a Patient with End-Stage Renal Impairment: A Case Report', European Journal of Case Reports in Internal Medicine, 2, http://dx.doi.org/10.12890/2015_000172

Holt SG; Gracey DM; Levy MT; Mudge DW; Irish AB; Walker RG; Baer R; Sevastos J; Abbas R; Boyd MA, 2014, 'A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection', AIDS Research and Therapy, 11, http://dx.doi.org/10.1186/1742-6405-11-35

Grover R; Sevastos J; Hayward C; Jabbour A; Keogh A; Kotlyar E; Macdonald P, 2013, 'Tenckhoff Catheter Implantation and Modified Peritoneal Dialysis As a Novel Therapeutic Approach in Diuretic Resistant Congestive Heart Failure: A Single-centre Case-series', Heart, Lung and Circulation, 22, pp. S89, http://dx.doi.org/10.1016/j.hlc.2013.05.211

Lee L; Sevastos J; Rainer S; Buckland ME, 2011, 'Giant cell tubulitis and tubular basement membrane immune deposits', Pathology, 43, pp. 383 - 386, http://dx.doi.org/10.1097/PAT.0b013e3283468772

Roberts DM; Smith MA; McMullan B; Sevastos J; Day RO, 2011, 'Acute kidney injury due to crystalluria following acute valacycolvir overdose', Kidney International, 79, pp. 574 - 575, http://dx.doi.org/10.1038/ki.2010.496

Brett J; Beresford R; Sevastos J; Day RO, 2011, 'Neem Extract Poisoning as a Cause of Renal Tubular Acidosis', Journal of Clinical Toxicology, 1, pp. 112, http://dx.doi.org/10.4172/2161-0495.1000112

Lee P; Sevastos J; Campbell LV, 2009, 'Surviving calciphylaxis', Journal of Bone and Mineral Metabolism, 27, pp. 247 - 250, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19057838

Sevastos J; Kennedy SE; Davis DR; Sam MJ; Peake PW; Charlesworth JA; Mackman N; Erlich JH, 2007, 'Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury', Blood, 109, pp. 577 - 583

&NA; , 2006, 'INTRAGRAFT GENE EXPRESSION PROFILING ASSOCIATED WITH TOLERANCE INDUCTION USING LENTIVIRAL-VECTOR MEDIATED GENE TRANSFER.', Transplantation, 82, pp. 1049 - 1049, http://dx.doi.org/10.1097/00007890-200607152-02990

Erlich JH; Sevastos J; Pussell BA, 2004, 'Goodpasture's disease: Antiglomerular basement membrane disease', Nephrology, 9, pp. 49 - 51, http://dx.doi.org/10.1111/j.1440-1797.2004.00244.x

Sevastos J; Lonergan M, 2003, 'Fibromuscular hyperplasia as a cause of transplant renal artery stenosis', Nephrology, 8, pp. 98 - 100, http://dx.doi.org/10.1046/j.1440-1797.2003.00138.x

Erlich JH; Sevastos J; Charlesworth JA; Davis DR, 2003, 'PAR-1 signalling contributes to renal dysfunction and to the regulationof tissue factor expression following renal ischaernia reperfusioninjury', Journal of the American Society of Nephrology, 14, pp. 626A - 626A

Back to profile page